Ega, Denmark

Soren Gregersen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Stevia Limited. Active years: 2017.



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Soren Gregersen: Innovator in Medicinal Supplements

Introduction

Soren Gregersen is a notable inventor based in Ega, Denmark. He has made significant contributions to the field of medicinal supplements, particularly in the treatment of non-insulin dependent diabetes mellitus and related conditions. His innovative approach combines dietary supplements with unique chemical structures to create effective medicaments.

Latest Patents

Soren Gregersen holds a patent for a medicament designed for the treatment of non-insulin dependent diabetes mellitus, hypertension, and/or metabolic syndrome. The patent describes a dietary supplement or medicament that includes substances with the chemical structure of bicyclo [3.2.1]octan or kaurene. This medicament is particularly useful for managing these health conditions. The possible substances mentioned in the patent include steviol, isosteviol, or stevioside. He has 1 patent to his name.

Career Highlights

Soren Gregersen is associated with Stevia Limited, where he applies his expertise in developing innovative health solutions. His work focuses on creating effective dietary supplements that can improve the quality of life for individuals suffering from metabolic disorders.

Collaborations

Soren collaborates with Per Bendix Jeppesen, contributing to the advancement of their shared goals in the field of medicinal supplements.

Conclusion

Soren Gregersen's work in developing a medicament for the treatment of non-insulin dependent diabetes mellitus and related conditions showcases his innovative spirit and dedication to improving health outcomes. His contributions to the field of dietary supplements are noteworthy and reflect his commitment to scientific advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…